These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23222938)

  • 41. Relationships between ankle blood pressure indices and major adverse cardiovascular events in people with and without type 2 diabetes.
    Mohammedi K; Pigeyre M; Bosch J; Yusuf S; Gerstein HC
    Cardiovasc Diabetol; 2024 Sep; 23(1):325. PubMed ID: 39227845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stronger association of triglyceride glucose index than the HOMA-IR with arterial stiffness in patients with type 2 diabetes: a real-world single-centre study.
    Wang S; Shi J; Peng Y; Fang Q; Mu Q; Gu W; Hong J; Zhang Y; Wang W
    Cardiovasc Diabetol; 2021 Apr; 20(1):82. PubMed ID: 33888131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of borderline ankle-brachial index with mortality and the incidence of peripheral artery disease in diabetic patients.
    Natsuaki C; Inoguchi T; Maeda Y; Yamada T; Sasaki S; Sonoda N; Shimabukuro M; Nawata H; Takayanagi R
    Atherosclerosis; 2014 Jun; 234(2):360-5. PubMed ID: 24732575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between glycated hemoglobin and low Ankle-Brachial Index: a cross-sectional observational study from the Beijing Vascular Disease Evaluation Study (BEST Study).
    Liu H; Liu J; Zhao H; Wang H;
    Int Angiol; 2019 Dec; 38(6):502-507. PubMed ID: 31782279
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ethnicity and risk of cardiovascular disease (CVD): 4.8 year follow-up of patients with type 2 diabetes living in Scotland.
    Malik MO; Govan L; Petrie JR; Ghouri N; Leese G; Fischbacher C; Colhoun H; Philip S; Wild S; McCrimmon R; Sattar N; Lindsay RS;
    Diabetologia; 2015 Apr; 58(4):716-25. PubMed ID: 25669630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcutaneous oxygen pressure as a predictor for short-term survival in patients with type 2 diabetes and foot ulcers: a comparison with ankle-brachial index and toe blood pressure.
    Fagher K; Katzman P; Löndahl M
    Acta Diabetol; 2018 Aug; 55(8):781-788. PubMed ID: 29707757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study.
    Ofstad AP; Gullestad L; Orvik E; Aakhus S; Endresen K; Ueland T; Aukrust P; Fagerland MW; Birkeland KI; Johansen OE
    Cardiovasc Diabetol; 2013 Aug; 12():126. PubMed ID: 23987834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trial.
    Diederichsen AC; Rasmussen LM; Søgaard R; Lambrechtsen J; Steffensen FH; Frost L; Egstrup K; Urbonaviciene G; Busk M; Olsen MH; Mickley H; Hallas J; Lindholt JS
    Trials; 2015 Dec; 16():554. PubMed ID: 26637993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of 1-hour postload plasma glucose as a suitable measurement in predicting type 2 diabetes and diabetes-related complications: A post hoc analysis of the 30-year follow-up of the Da Qing IGT and Diabetes Study.
    Peng M; He S; Wang J; An Y; Qian X; Zhang B; Zhang L; Chen B; Yang Z; Li G; Gong Q;
    Diabetes Obes Metab; 2024 Jun; 26(6):2329-2338. PubMed ID: 38488254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The association between fasting plasma glucose and all-cause and cause-specific mortality by gender: The rural Chinese cohort study.
    Liu L; Chen X; Liu Y; Sun X; Yin Z; Li H; Zhang M; Wang B; Ren Y; Zhao Y; Liu D; Zhou J; Liu X; Zhang D; Cheng C; Liu F; Zhou Q; Xu Q; Xiong Y; Liu J; You Z; Hong S; Wang C; Hu D
    Diabetes Metab Res Rev; 2019 May; 35(4):e3129. PubMed ID: 30657630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arterial stiffness as a risk factor for cardiovascular events and all-cause mortality in people with Type 2 diabetes.
    Sharif S; Visseren FLJ; Spiering W; de Jong PA; Bots ML; Westerink J;
    Diabet Med; 2019 Sep; 36(9):1125-1132. PubMed ID: 30920676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of low ankle-brachial index, elevated plasma fibrinogen and CRP across Framingham risk categories: data from the National Health and Nutrition Examination Survey (NHANES) 1999-2004.
    Dhangana R; Murphy TP; Pencina MJ; Zafar AM
    Atherosclerosis; 2011 May; 216(1):174-9. PubMed ID: 21414621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study.
    Wei M; Gaskill SP; Haffner SM; Stern MP
    Diabetes Care; 1998 Jul; 21(7):1167-72. PubMed ID: 9653614
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Ankle Brachial Index Exhibits Better Association of Cardiovascular Prognosis Than Non-High-Density Lipoprotein Cholesterol in Type 2 Diabetes.
    Chang LH; Hwu CM; Chu CH; Won JG; Kwok CF; Lin HD; Chen HS; Lin YC; Lin LY
    Am J Med Sci; 2016 May; 351(5):492-8. PubMed ID: 27140708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The combination of the ankle brachial index and brachial ankle pulse wave velocity exhibits a superior association with outcomes in diabetic patients.
    Chang LH; Lin HD; Kwok CF; Won JG; Chen HS; Chu CH; Hwu CM; Kuo CS; Jap TS; Shih KC; Lin LY
    Intern Med; 2014; 53(21):2425-31. PubMed ID: 25365999
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The sweet spot: fasting glucose, cardiovascular disease, and mortality in older adults with diabetes: a nationwide population-based study.
    Lee JH; Han K; Huh JH
    Cardiovasc Diabetol; 2020 Apr; 19(1):44. PubMed ID: 32238157
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetes.
    Huang Z; Klaric L; Krasauskaite J; McLachlan S; Strachan MWJ; Wilson JF; Price JF
    Cardiovasc Diabetol; 2022 Apr; 21(1):62. PubMed ID: 35477395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differences in the ankle-brachial index in the general population after 4 years of follow-up.
    Lahoz C; Garcia-Fernandez T; Barrionuevo M; Vicente I; Gonzalez-Alegre T; Mostaza JM
    Vasa; 2013 Mar; 42(2):112-9. PubMed ID: 23485838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination of low ankle-brachial index and high ankle-brachial index difference for mortality prediction.
    Tsai WC; Lee WH; Chen YC; Liu YH; Chang CT; Hsu PC; Chu CY; Lin TH; Lee CS; Lee CH; Voon WC; Lai WT; Sheu SH; Su HM
    Hypertens Res; 2021 Jul; 44(7):850-857. PubMed ID: 33707757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
    Wada T; Haneda M; Furuichi K; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Shimizu M; Toyama T; Hara A; Makino H;
    Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.